Parkinsonism: candidate disorder for implanted pumps?
D000978:Antiparkinson Agents / Q000008:administration & dosage*; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000172:deficiency; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007260:Infusion Pumps; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D011954:Receptors, Dopamine / Q000378:metabolism
D000978:Antiparkinson Agents; D018377:Neurotransmitter Agents; D011954:Receptors, Dopamine; D007980:Levodopa; D004298:Dopamine